The Cancer Nation Policy Roundtable is a semi-annual meeting convening stakeholders in the cancer community. Participants discuss pressing issues related to cancer research, development of new cancer therapies, and the delivery of quality cancer care. In 2025, we are celebrating 25 years of Roundtable meetings.

Roundtable presenters range from public and health policy experts, to cancer survivors and patient advocates, and representatives of the National Institutes of Health (NIH), Food and Drug Administration (FDA), Centers for Medicare and Medicaid Services (CMS), Congressional health policy advisors and leaders in health insurance, pharmaceutical, and biotechnology industries.

These meetings are a great opportunity for interested parties to come together and discuss timely and compelling issues. Specific objectives and outcomes are unique to each meeting, however past meetings have focused on topics such as clinical trials, issues for older adults, expanded access programs, Medicare reimbursement, health care reform, and other relevant topics.